1.60
price up icon5.26%   0.08
pre-market  Vorhandelsmarkt:  1.55   -0.05   -3.13%
loading

Quince Therapeutics Inc Aktie (QNCX) Neueste Nachrichten

pulisher
Jun 19, 2025

Quince Therapeutics Announces Closing of Up to $22 Million Private Placement of Securities - BioSpace

Jun 19, 2025
pulisher
Jun 18, 2025

Quince Therapeutics announces closing of up to $22 million private placement of securities - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Quince Therapeutics Announces Closing of Up to $22 Million Private Placement of Securities | QNCX Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 16, 2025

June 2025's Promising Penny Stocks For Savvy Investors - simplywall.st

Jun 16, 2025
pulisher
Jun 15, 2025

D. Boral Capital Reaffirms Buy Rating for Quince Therapeutics (NASDAQ:QNCX) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Takes $57,000 Position in Quince Therapeutics, Inc. (NASDAQ:QNCX) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Quince Therapeutics (QNCX) Analyst Rating Update: Buy Rating Mai - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Quince Therapeutics Raises $11.5M in Private Placement - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

Quince Therapeutics Announces Pricing of Up to $22 Million Priva - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Quince Therapeutics Announces Pricing of Up to $22 Million Private Placement of Securities - BioSpace

Jun 13, 2025
pulisher
Jun 13, 2025

Quince Therapeutics (QNCX) Secures $11.5 Million Through New Sec - GuruFocus

Jun 13, 2025
pulisher
Jun 12, 2025

Quince Therapeutics (QNCX) Secures $11.5M Through Private Placem - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Quince Therapeutics (QNCX) Secures $11.5 Million Through New Securities Agreement | QNCX Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Quince Therapeutics Prices $22 Million Private Placement of Shares, Warrants - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

Quince Therapeutics Announces Pricing of Up to $22 Million Private Placement of Securities | QNCX Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Quince Therapeutics Announces Pricing Of Up To $22 Mln Private Placement Of Securities - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

Quince Therapeutics stock soars after announcing $11.5 million private placement - Investing.com Nigeria

Jun 12, 2025
pulisher
Jun 08, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Quince Therapeutics (QNCX) and Moderna (MRNA) - The Globe and Mail

Jun 08, 2025
pulisher
Jun 05, 2025

Quince Therapeutics Approves Key Proposals at Annual Meeting - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

Quince Therapeutics’ (QNCX) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Transcript : Quince Therapeutics, Inc.Shareholder/Analyst Call - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Quince Therapeutics, Inc. (NASDAQ:QNCX) Shares Acquired by Northern Trust Corp - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Quince Therapeutics (QNCX) Stock Rating and Price Target Update - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Quince Therapeutics Exceeds 75% Enrollment in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia - BioSpace

Jun 04, 2025
pulisher
Jun 03, 2025

Quince Therapeutics Says Enrollment for Phase 3 Clinical Trial in Ataxia-Telangiectasia Exceeds 75% - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Quince Therapeutics (QNCX) Phase 3 Trial Achieves Major Progress - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Quince Therapeutics Exceeds 75% Enrollment in Pivotal Phase 3 NE - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Quince Therapeutics (QNCX) Phase 3 Trial Achieves Major Progress in Enrollment | QNCX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 02, 2025

Quince Therapeutics, Inc. (NASDAQ:QNCX) Short Interest Down 42.9% in May - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

FY2025 Earnings Forecast for TSE:WEE Issued By Roth Capital - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Quince Therapeutics, Inc. (NASDAQ:QNCX) Given Consensus Rating of “Buy” by Brokerages - Defense World

Jun 01, 2025
pulisher
May 30, 2025

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

May 30, 2025
pulisher
May 30, 2025

HC Wainwright Has Positive Estimate for ORKA Q2 Earnings - Defense World

May 30, 2025
pulisher
May 30, 2025

Q2 EPS Estimate for Century Therapeutics Raised by Analyst - Defense World

May 30, 2025
pulisher
May 21, 2025

Rani Therapeutics (NASDAQ:RANI) Stock Price Up 7% – Here’s What Happened - Defense World

May 21, 2025
pulisher
May 17, 2025

Finch Therapeutics Group (NASDAQ:FNCH) and Quince Therapeutics (NASDAQ:QNCX) Head to Head Comparison - Defense World

May 17, 2025
pulisher
May 17, 2025

Brookline Capital Management Forecasts QNCX Q2 Earnings - Defense World

May 17, 2025
pulisher
May 16, 2025

Quince Therapeutics secures USPTO nod for A-T treatment patent - MSN

May 16, 2025
pulisher
May 15, 2025

Quince Therapeutics: Data In Ataxia-Telangiectasia Scheduled For Early 2026 (NASDAQ:QNCX) - Seeking Alpha

May 15, 2025
pulisher
May 15, 2025

Quince Therapeutics Reports Q1 2025 Results and Strategic Updates - TipRanks

May 15, 2025
pulisher
May 13, 2025

Quince Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results - BioSpace

May 13, 2025
pulisher
May 13, 2025

Quince Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

Quince Therapeutics, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

Quince Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results | QNCX Stock News - GuruFocus

May 13, 2025
pulisher
May 12, 2025

QNCXQuince Latest Stock News & Market Updates - Stock Titan

May 12, 2025
pulisher
May 10, 2025

Quince Therapeutics (QNCX) Expected to Announce Earnings on Monday - Defense World

May 10, 2025
pulisher
May 07, 2025

Quince Therapeutics, Inc. (NASDAQ:QNCX) Receives Average Recommendation of “Buy” from Analysts - Defense World

May 07, 2025
pulisher
May 05, 2025

Why Faraday Future Intelligent Electric Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - Benzinga

May 05, 2025
pulisher
May 04, 2025

Quince Therapeutics (QNCX) CEO to Present at Life Sciences Confe - GuruFocus

May 04, 2025
pulisher
May 04, 2025

Quince Therapeutics (QNCX) CEO to Present at Life Sciences Conference - GuruFocus

May 04, 2025
pulisher
May 02, 2025

Geode Capital Management LLC Has $703,000 Position in Quince Therapeutics, Inc. (NASDAQ:QNCX) - Defense World

May 02, 2025
pulisher
Apr 30, 2025

Quince Therapeutics to Present at Citizens Life Sciences Conference - BioSpace

Apr 30, 2025
pulisher
Apr 29, 2025

Quince Therapeutics Inc (QNCX) Stock: 52-Week Performance Insights and Trading Volume - investchronicle.com

Apr 29, 2025
pulisher
Apr 29, 2025

Ratios Uncovered: Breaking Down Quince Therapeutics Inc (QNCX)’s Trailing Twelve Months Metrics - DWinneX

Apr 29, 2025
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):